PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCQ99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $130,449
Award facts
- Contract value 100% obligated
- $130,448.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 22, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $130,448.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for completion by January 23, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, through its parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's contract portfolio demonstrates extensive capability in delivering specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award represents a continuation of AmerisourceBergen's role as a primary supplier under the DLA's pharmaceutical prime vendor program, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with essential medical products through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2D826FCQ99?
SPE2D826FCQ99 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 22, 2026.
How much is contract SPE2D826FCQ99 worth?
The government has obligated $130,449 on SPE2D826FCQ99.
Is contract SPE2D826FCQ99 an order under another contract?
Yes. SPE2D826FCQ99 is a delivery order under SPE2DX22D0010, an indefinite delivery contract.
Was contract SPE2D826FCQ99 competed?
The extent of competition for SPE2D826FCQ99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award